Rapid Diagnostic Assays for Self-Monitoring of Acute or Rebound HIV-1 Infection
This grant opportunity accepts Phase I and Fast Track proposals, but not Direct-to-Phase II proposals. It anticipates awarding 4-5 grants. Phase I funding offers $300,000 per year for up to 2 years, and Phase II funding offers up to $2 million total for up to 3 years. The grant focuses on developing domestic innovations to combat HIV in the United States, supporting the goal of a 90% reduction…
Source
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care
Health Resources and Services Administration
-
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
-
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institutes of Health
-
DoD funding for HIV prevention and treatment in foreign military health systems
Dept. of the Army -- USAMRAA
-
Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers